F0101B). Quadrant markers were set based on isotype control staining (MAB003, data not shown). Staining was performed using our Staining Membrane-Associated Proteins protocol." alt="HEK293 human embryonic kidney cell line transfected with either (A) Human GPRC5D or (B) irrelevant protein, and eGFP was stained with Mouse anti-Human GPRC5D Monoclonal Antibody (Catalog # MAB63001) followed by Allophycocyanin-conjugated anti-Mouse IgG Secondary Antibody (F0101B). Quadrant markers were set based on isotype control staining (MAB003, data not shown). Staining was performed using our Staining Membrane-Associated Proteins protocol." class="big_thumb" />
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS571] - Brain, Glioblastoma](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS571-img0005.jpg "Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS571] - Brain, Glioblastoma")
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS571] - Analysis of anti-GPRC5D antibody with human kidney, renal tubule.](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS571-img0002.jpg)
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS571] - Brain, Substantia nigra](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS571-img0003.jpg)
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS571] - Brain, Amygdala, Neurons and Glia](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS571-img0004.jpg)
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS568] - Brain, Glioblastoma](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS568-img0004.jpg "Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS568] - Brain, Glioblastoma")
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS568] - Analysis of anti-GPRC5D antibody with human kidney, renal tubule.](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-NLS568-img0001.jpg)
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS568] - Brain, Amygdala, neurons and glia](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS568-img0002.jpg)
![Immunohistochemistry-Paraffin: GPRC5D Antibody [NLS568] - Brain, Caudate, Neurons and Glia](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Immunohistochemistry-Paraffin-NLS568-img0005.jpg)
![Western Blot: GPRC5D Antibody (6D9) [H00055507-M01] - GPRC5D monoclonal antibody (M01), clone 6D9. Analysis of GPRC5D expression in human kidney.](http://images.novusbio.com/fullsize/GPRC5D-Antibody-6D9-Western-Blot-H00055507-M01-img0002.jpg "Western Blot: GPRC5D Antibody (6D9) [H00055507-M01] - GPRC5D monoclonal antibody (M01), clone 6D9. Analysis of GPRC5D expression in human kidney.")
![ELISA: GPRC5D Antibody (6D9) [H00055507-M01] - Detection limit for recombinant GST tagged GPRC5D is 0.03 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/GPRC5D-Antibody-6D9-ELISA-H00055507-M01-img0003.jpg)
![Western Blot: GPRC5D Antibody [H00055507-B01P] - Analysis of GPRC5D expression in transfected 293T cell line by GPRC5D polyclonal antibody. Lane 1: GPRC5D transfected lysate(37.95 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Western-Blot-H00055507-B01P-img0004.jpg "Western Blot: GPRC5D Antibody [H00055507-B01P] - Analysis of GPRC5D expression in transfected 293T cell line by GPRC5D polyclonal antibody. Lane 1: GPRC5D transfected lysate(37.95 KDa). Lane 2: Non-transfected lysate.")
![Flow Cytometry: GPRC5D Antibody [H00055507-B01P] - Analysis of negative control 293 cells (Black) and GPRC5D expressing 293 cells (Green) using GPRC5D purified mouse polyclonal antibody.](http://images.novusbio.com/fullsize/GPRC5D-Antibody-Flow-Cytometry-H00055507-B01P-img0003.jpg)
![SDS-Page: Recombinant Human GPRC5D Protein [H00055507-Q01] - 12.5% SDS-PAGE Stained with Coomassie Blue.](http://images.novusbio.com/fullsize/qc_test-H00055507-Q01-1.jpg "SDS-Page: Recombinant Human GPRC5D Protein [H00055507-Q01] - 12.5% SDS-PAGE Stained with Coomassie Blue.")
![ELISA: GPRC5D Antibody (19) - Azide and BSA Free [NBP3-26101] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26101, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.](http://images.novusbio.com/fullsize/nbp3-26101_mouse-gprc5d-mab-19-azide-and-bsa-free-12620241540463.png "ELISA: GPRC5D Antibody (19) - Azide and BSA Free [NBP3-26101] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26101, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.")
![Flow Cytometry: GPRC5D Antibody (19) [NBP3-26101] - Flow cytometric analysis of Human GPRC5D expression on CHO-K1-transfected cells were stained with NBP3-26101, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/nbp3-26101_mouse-gprc5d-mab-19-azide-and-bsa-free-235202511354117.png)
![ELISA: GPRC5D Antibody (10) - Azide and BSA Free [NBP3-26099] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26099, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.](http://images.novusbio.com/fullsize/nbp3-26099_mouse-gprc5d-mab-10-azide-and-bsa-free-12620241351412.png "ELISA: GPRC5D Antibody (10) - Azide and BSA Free [NBP3-26099] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26099, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.")
![Flow Cytometry: GPRC5D Antibody (10) [NBP3-26099] - Flow cytometric analysis of Human GPRC5D expression on CHO-K1-transfected cells were stained with NBP3-26099, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/nbp3-26099_mouse-gprc5d-mab-10-azide-and-bsa-free-235202516144329.png)
![ELISA: GPRC5D Antibody (12) - Azide and BSA Free [NBP3-26100] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26100, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.](http://images.novusbio.com/fullsize/nbp3-26100_mouse-gprc5d-mab-12-azide-and-bsa-free-13620242234502.png "ELISA: GPRC5D Antibody (12) - Azide and BSA Free [NBP3-26100] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26100, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.")
![Flow Cytometry: GPRC5D Antibody (12) [NBP3-26100] - Flow cytometric analysis of Human GPRC5D expression on CHO-K1-transfected cells were stained with NBP3-26100, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/nbp3-26100_mouse-gprc5d-mab-12-azide-and-bsa-free-23520251664785.png)
![ELISA: GPRC5D Antibody (06) - Azide and BSA Free [NBP3-26097] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26097, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.](http://images.novusbio.com/fullsize/nbp3-26097_mouse-gprc5d-mab-06-azide-and-bsa-free-136202422345025.png "ELISA: GPRC5D Antibody (06) - Azide and BSA Free [NBP3-26097] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26097, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.")
![ELISA: GPRC5D Antibody (08) - Azide and BSA Free [NBP3-26098] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26098, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.](http://images.novusbio.com/fullsize/nbp3-26098_mouse-gprc5d-mab-08-azide-and-bsa-free-1362024223418.png "ELISA: GPRC5D Antibody (08) - Azide and BSA Free [NBP3-26098] - Measured by its binding ability in a functional ELISA. Immobilized Human GPRC5D-VLP protein at 5 ug/mL (100 uL/well) can bind NBP3-26098, the EC50 is 0.5-5 ng/mL. The VLP isotype control Protein is the negative control.")
